Antiplatelet and Anticoagulant management for Regional Anesthesia

Size: px
Start display at page:

Download "Antiplatelet and Anticoagulant management for Regional Anesthesia"

Transcription

1 Antiplatelet and Anticoagulant management for Regional Anesthesia Deborah Richman MBCHB, FFA(SA) Director of Pre-Operative Services Department of Anesthesia Stony Brook MedicineStony Brook, NY SPAQI Immediate Past-President The 13 th Annual Perioperative Medicine Summit Fort Lauderdale, Florida

2 Disclosures No financial disclosures SPAQI Immediate Past President #Periop2018 The 13 th Annual Perioperative Medicine Summit Fort Lauderdale, Florida

3 Learning Objectives After attending this session the learner will be able to: List the types and advantages of regional blocks Describe the risks of blocks Provide medication management instructions to patients on antiplatelet agents and anticoagulants, who are planning on a regional anesthesia technique for their procedure

4 Analgesia Intraop: Opiates IV neuraxial NSAIDs Acetaminophen Local Regional blocks Post op: IV or PO opiates and block catheters

5 Complications of analgesics Opiates Allergies Toxicity Side effects Histamine release PONV Respiratory depression Confusion Constipation Weakness/dizziness falls Tolerance/Addiction/Abuse Regional / local Allergies Toxicity Local effects Hematoma Infection Nerve injury

6 Regional anesthesia Abdominal Thoracic nerve blocks femoral/sciatic/adductor canal/ Field block brachial plexus/ nerve blocks/ Bier s block Lower extremity epidural/ intercostal/paravertebral Upper extremity spinal/ epidural/tap block ankle block/penile block Ophthalmology retrobulbar/peribulbar/subtenon/topical Risk of hematoma #Periop2018 Non compressible spaces Closed space spinal column

7 Neuraxial anesthesia / analgesia #Periop2018

8 Regional anesthesia any time you stick a needle anywhere, you run the risk of introducing infection, causing bleeding or damaging a nerve.

9 Spinal/epidural complications 1. Drug allergy or toxicity 2. Anatomic: Difficulty placing them Failed block 3. Bleeding Skin Sub-q Epidural hematoma 4. Back pain 5. Infection epidural abscess 6. Nerve damage 7. Spinal tap or persistent CSF leak post dural puncture headache(pdph) 8. High spinal 9. Hypotension Reviewing contraindications and avoiding block may be appropriate

10 Rare True incidence not known US: 3.7 million epidurals OB epidurals: 0.6 per 100,000 Non-OB: 18.5 per 100,000 (1: 5450) Vascular surgery Teaching hospital High comorbidity score Rosero EB Acta Anesth Scand. Jul Vol 60,:6 pp Sweden 1.26 million spinals and 450K epidurals Spinal hematoma(1: ) < Epidural (1: ) Obstetrics < other patients Females TKR / hip fracture 11/33 assoc with coagulopathy/thromboprophylaxis Moen V. Anesthesiology. 2004;101(4):950. Frequency is increasing and may be as high as 1 in 3000 in some patient populations. Risk factors Increasing age, Anatomical abnormalities of spine Underlying coagulopathy Procedural difficulty Indwelling neuraxial catheter with anticoagulation therapy Prompt diagnosis and management needed to prevent permanent neurological sequelae. #Periop2018 Neuraxial hematoma after anesthesia

11 Avoiding epidural hematoma 1. Careful patient selection 2. Meticulous technique 3. Appropriate medication management

12 Case 1 57 yr. old male for TKR under spinal anesthesia and femoral nerve block for analgesia Advantages Less DVT Less blood loss Less transfusion Better bone cement interface Better ROM of knee at 1 week and 30 days MI 14 months ago with PCI and DES Meds include DAPT ASA 81mg and Clopidogrel 75mg Cardiol. cleared patient; to hold both drugs for 5 days

13 ARS question Case 1 For the planned procedure and anesthesia you should recommend that he: A. Stays on DAPT perioperatively B. He should stop the ASA for 7 days and continue the clopidogrel C. He should stop the clopidogrel for 5 days and continue the ASA D. He should stop the clopidogrel for 7 days and continue the ASA E. You agree with his cardiologist - he should stop both clopidogrel and ASA for 5 days

14 The magnitude of incremental bleeding risk in patients treated with antiplatelet therapy who undergo surgery is uncertain (157,158). If P2Y12 inhibitor therapy needs to be held in patients being treated with DAPT after stent implantation, continuation of aspirin therapy if possible is recommended #Periop2018 Levine, GN, et al.

15 Patient selection Benefit of regional vs. risk of holding anticoagulant/ antiplatelet therapy #Periop2018

16 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery Choice of Anesthetic Technique and Agent Fleisher LA, et al.2014 ACC/AHA Perioperative Guideline

17 Neuraxial vs. General Anesthesia 1. Lower-limb revascularization 1 No difference in MI rate 2. Abdominal aortic surgery 2 No difference in MI or ischemia rate 1. Barbosa FT etal. Cochrane Database Syst Rev. 2013;7:CD Norris EJ etal. Anesthesiology. 2001;95: Conclusion regional not cardio-protective No benefit

18 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery Perioperative Pain Management: Recommendations Class IIa 1. Neuraxial anesthesia for postoperative pain relief can be effective in patients undergoing abdominal aortic surgery to decrease the incidence of perioperative MI (348). (Level of Evidence:B) Class IIb 1. Perioperative epidural analgesia may be considered to decrease the incidence of preoperative cardiac events in patients with a hip fracture (349). (Level of Evidence: B) RCT: 64 patients - MI/HF/ischemia/AF Fleisher LA, et al.2014 ACC/AHA Perioperative Guideline Matot I, etal Anesthesiology. 2003;98: #Periop2018

19 Which is better? GA or neuraxial? Very few places where one is definitively better Regional blocks Longer to place Longer to discharge Deep vein thrombosis (DVT) reduced Less relevant in age of universal prophylaxis Blood loss reduced in total joint replacements Use of tranexamic acid makes this less relevant?cancer recurrence Opioid avoidance Direct effect on tumor cells Reduction of stress response Sekandarzad, MW. A&A May Vol 124(5), p

20 Does regional anaesthesia really improve outcome? Specific endpoints assessed Inflammation Cancer Stress Less opioids Platelet function GI function Mixed results. it remains unclear whether regional anaesthesia reduces mortality. However, regional anaesthesia offers superior analgesia over opioidbased analgesia, and a significant reduction in postoperative pain is still a worthwhile outcome. S. C. Kettner, etal. BJA 2011, vol107, Issue suppl i90-i95

21 Non-cardiac complications and choice of anesthesia Evidence is mixed and conflicting: Neuraxial better? GI/ileus - ERAS DVT 1 month mortality Post op confusion? Clinical significance Cost? Continuous analgesia No difference? PONV PE LOS Pneumonia #Periop2018

22 Avoiding epidural hematoma 1. Careful patient selection 2. Meticulous technique 3. Appropriate medication management Placement of block/catheter Removal of catheter Restarting medication

23 Medication management Simplify when possible to improve patient compliance

24 Supplements and Herbal agents Effect is minimal unless combined with other agents Surgeon usually wants these held Vit E Fish Oils Ginger Ginkgo Horlocker, TT. Regional Anesthesia and Pain Medicine: Jan-Feb 2010 Vol 35 - Iss 1 - p Garlic Hold for 7 days Ginkgo and Ginger shorter t1/2 #Periop2018

25 1000 procedures with neuraxial Majority: ASA and NSAIDs N=25 Heparin No major bleeds/ neuro sequelae Conclusion: ASA and NSAIDs safe in the arthritic population who depend on drugs for mobility #Periop2018

26 Neuroaxial anesthesia and bleeding risk ASRA guidelines 1 : Supplements Herbals Aspirin NSAIDS Clopidogrel 7 days Prasugrel 7-10 days Ticagrelor 5-7 days Ticlopidine 14 days Coumadin normal INR Practically: Hold 4-5 doses depending on INR Check INR morning of surgery 1. Horlocker, TT. Regional Anesthesia and Pain Medicine: Jan-Feb 2010 Vol 35 - Iss 1 - p

27 57 yr. old male for TKR under spinal anesthesia and femoral nerve block for analgesia For the planned procedure and anesthesia you should recommend that he: A. Stays on DAPT perioperatively B. He should stop the ASA for 7 days and continue the clopidogrel C. He should stop the clopidogrel for 5 days and continue the ASA D. He should stop the clopidogrel for 7 days and continue the ASA E. You agree with his cardiologist - he should stop both clopidogrel and ASA for 5 days

28 Neuroaxial anesthesia and bleeding risk ASRA guidelines 1 : Heparin normal PTT 6 hours after IV. May do block if < SC daily dose Delay dose till > 1 hr. after block placed LMWH - block Prophylactic dose hours after last dose Therapeutic dose 24 hours after Fondaparinux no evidence: block not recommended Glycoprotein IIb/IIIa Abciximab 48 hours Tirofiban/eptifibatide 4-8 hours NOACs: next slide 1. Horlocker, TT. Regional Anesthesia and Pain Medicine: Jan-Feb 2010 Vol 35 - Iss 1 - p

29 Horlocker, TT. Regional Anesthesia and Pain Medicine: Jan-Feb 2010 Vol 35 - Iss 1 - p

30 Memorizing this for your practice ld o H d l al s g ru 7 r fo s y a d Please NO!! There is help #Periop2018

31 ASRA app $ / User friendly

32 Summary Consider: Risk of hematoma vs. advantage of block Risk of stopping ac/antiplt agent vs. advantage of block Refer to ASRA guidelines Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition) Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications: es_in.2.aspx Multidisciplinary consultation for best individualized management plan

33 Selected References Horlocker, TT. ASRA guidelines. Regional Anesthesia and Pain Medicine: Jan-Feb 2010 Vol 35 - Iss 1 - p Rosero EB, Joshi GP. Nationwide incidence of serious complications of epidural analgesia in the United States. Acta Anaesthesiol Scand 2016; 60:810. S. C. Kettner, H. Willschke, P. Marhofer; Does regional anaesthesia really improve outcome?, BJA: British Journal of Anaesthesia, Volume 107, Issue suppl_1, 1 December 2011, Pages i90 i95,

34 Thank you Deborah Richman MBCHB, FFA(SA) Stony BrookMedicine Stony Brook, NY SPAQI Immediate Past President #Periop2018

35 Symptoms of spinal hematoma Severe back pain (38%) sensory (14%) motor deficit (46%) Urinary retention (6%) Not all of these symptoms have to be present at the same time. Paraplegia develop hours #Periop2018 Vandermeulen EP. A&A 1994;79:

ANAESTHESIA FOR LIVER SURGERY

ANAESTHESIA FOR LIVER SURGERY Seminars at 21 Portland Place ANAESTHESIA FOR LIVER SURGERY This seminar is organised in conjunction with the Liver Intensive Care Group of Europe Wednesday 18 th October 2006 Seminars at 21 Portland Place

More information

NEURAXIAL BLOCKADE AND ANTICOAGULANTS

NEURAXIAL BLOCKADE AND ANTICOAGULANTS Soli Deo Gloria NEURAXIAL BLOCKADE AND ANTICOAGULANTS Lecture 4 Developing Countries Regional Anesthesia Lecture Series Daniel D. Moos CRNA, Ed.D. U.S.A. moosd@charter.net Disclaimer Every effort was made

More information

Timing of Surgery After Percutaneous Coronary Intervention

Timing of Surgery After Percutaneous Coronary Intervention Timing of Surgery After Percutaneous Coronary Intervention Deepak Talreja, MD, FACC Bayview/EVMS/Sentara Outline/Highlights Timing of elective surgery What to do with medications Stopping anti-platelet

More information

Funding: The ASRA Consensus Conference was funded by unrestricted educational grants from: Pharmacia & Upjohn Company and Aventis Pharmaceuticals

Funding: The ASRA Consensus Conference was funded by unrestricted educational grants from: Pharmacia & Upjohn Company and Aventis Pharmaceuticals Regional Anesthesia in the Anticoagulated Patient - Defining the Risks Published by the American Society of Regional Anesthesia and Pain Medicine This document has been developed by a Consensus Conference

More information

ANTI COAGULATION AND BLOCKS

ANTI COAGULATION AND BLOCKS ANTI COAGULATION AND BLOCKS Dr S.M. SENTHIL NATHAN, MD, COIMBATORE NEDICAL COLLEGE, COIMBATORE. We now live in a scenario doomed with lot of co-morbidities.one of the important being the cardiovascular

More information

Anesthesia for Total Hip and Knee Arthroplasty

Anesthesia for Total Hip and Knee Arthroplasty Anesthesia for Total Hip and Knee Arthroplasty Typical approach Describe anesthesia technique Rather Describe issues with THA and TKA How anesthesia can modify Issues Total Hip Total Knee Blood Loss ++

More information

Consensus Statement for Management of Anticoagulants and Antiplatelet drugs in Patients with Hip Fracture

Consensus Statement for Management of Anticoagulants and Antiplatelet drugs in Patients with Hip Fracture Consensus Statement for Management of Anticoagulants and Antiplatelet drugs in Patients with Hip Fracture Patients with hip fractures should be operated on within 36 hours of presentation wherever possible.

More information

Role and safety of epidural analgesia

Role and safety of epidural analgesia Anaesthesia for Liver Resection Surgery The Association of Anaesthetists Seminars 21 Portland Place, London Thursday 15 th December 2005 Role and safety of epidural analgesia Lennart Christiansson MD,

More information

Perioperative VTE Prophylaxis

Perioperative VTE Prophylaxis Perioperative VTE Prophylaxis Gregory J. Misky, M.D. Assistant Professor of Medicine University Of Colorado Denver You recommend the following 72 y.o. man admitted for an elective R hip repair. Patient

More information

The Future of Oral Antiplatelets in PAD and CAD Christopher Paris, MD, FACC, FSCAI

The Future of Oral Antiplatelets in PAD and CAD Christopher Paris, MD, FACC, FSCAI The Future of Oral Antiplatelets in PAD and CAD Christopher Paris, MD, FACC, FSCAI Interventional Cardiologist Cardiovascular Institute of the South Director of Cardiovascular Services St. Charles Parish

More information

Regional anaesthesia in the patient receiving antithrombotic and antiplatelet therapy

Regional anaesthesia in the patient receiving antithrombotic and antiplatelet therapy British Journal of Anaesthesia 107 (S1): i96 i106 (2011) doi:10.1093/bja/aer381 Regional anaesthesia in the patient receiving antithrombotic and antiplatelet therapy T. T. Horlocker Department of Anesthesiology,

More information

INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY

INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY N.E. Pearce INTRODUCTION Preventable death Cause of morbidity and mortality Risk factors Pulmonary embolism

More information

Disclosures: This presenter has no financial relationships with commercial interests.

Disclosures: This presenter has no financial relationships with commercial interests. Session: L310 Session: L439 Tough Choices: Regional or General Anesthesia in a Very Elderly Patient Jason S. Lane, M.D., M.P.H. Vanderbilt University Medical Center, Nashville, TN Disclosures: This presenter

More information

Top 5 (or so) Hematology Consults. Tom DeLoughery, MD FACP FAWM. Oregon Health and Sciences University DISCLOSURE

Top 5 (or so) Hematology Consults. Tom DeLoughery, MD FACP FAWM. Oregon Health and Sciences University DISCLOSURE Top 5 (or so) Hematology Consults Tom FACP FAWM Oregon Health and Sciences University DISCLOSURE Relevant Financial Relationship(s) Speaker Bureau - None Consultant/Research none 1 What I am Talking About

More information

Show Me the Evidence: Epidurals, PVBs, TAP Blocks Christopher L. Wu, MD Professor of Anesthesiology The Johns Hopkins Hospital

Show Me the Evidence: Epidurals, PVBs, TAP Blocks Christopher L. Wu, MD Professor of Anesthesiology The Johns Hopkins Hospital Show Me the Evidence: Epidurals, PVBs, TAP Blocks Christopher L. Wu, MD Professor of Anesthesiology The Johns Hopkins Hospital Overview Review overall (ERAS and non-eras) data for EA, PVB, TAP Examine

More information

Regional anaesthesia and antithrombotic drugs

Regional anaesthesia and antithrombotic drugs Regional anaesthesia and antithrombotic drugs G Davies FRCA MR Checketts FRCA Matrix references 1A02, 2G01 Key points Vertebral canal haematoma is a rare but potentially devastating complication of central

More information

Dual Antiplatelet Therapy Made Practical

Dual Antiplatelet Therapy Made Practical Dual Antiplatelet Therapy Made Practical David Parra, Pharm.D., FCCP, BCPS Clinical Pharmacy Program Manager in Cardiology/Anticoagulation VISN 8 Pharmacy Benefits Management Clinical Associate Professor

More information

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease Developed in Collaboration with American Association for Thoracic Surgery, American

More information

Post-procedure dose ok after hours. 12 hours (q 24h dosing only) assuming surgical hemostasis; second dose 24 hours after first dose.

Post-procedure dose ok after hours. 12 hours (q 24h dosing only) assuming surgical hemostasis; second dose 24 hours after first dose. Medication Time to wait after last dose Post-procedure dose ok after hours Can pull catheter hours after last dose Can give next dose hours after pulling catheter Enoxaparin (Lovenox) Prophylactic dose

More information

ASA Closed Claims Project: Regional Anesthesia Claims 1990 or later Lorri A. Lee MD Department of Anesthesiology University of Washington, Seattle, WA

ASA Closed Claims Project: Regional Anesthesia Claims 1990 or later Lorri A. Lee MD Department of Anesthesiology University of Washington, Seattle, WA ASA Closed Claims Project: Regional Anesthesia Claims 1990 or later Lorri A. Lee MD Department of Anesthesiology, Seattle, WA OVERVIEW 1. Closed Claims Project 2. Peripheral Nerve Blocks 3. Neuraxial Claims

More information

Analgesia for ERAS programs. Dr Igor Lemech VMO Anaesthetist Wagga Wagga Base Hospital

Analgesia for ERAS programs. Dr Igor Lemech VMO Anaesthetist Wagga Wagga Base Hospital Analgesia for ERAS programs Dr Igor Lemech VMO Anaesthetist Wagga Wagga Base Hospital Disclosure I have received honoraria from Mundipharma and MSD The new Wagga Wagga Rural Referral Centre Scope Analgesic

More information

Anticoagulation for prevention of venous thromboembolism

Anticoagulation for prevention of venous thromboembolism Anticoagulation for prevention of venous thromboembolism Original article by: Michael Tam Note: updated in June 2009 with the eighth edition (from the seventh) evidence-based clinical practice guidelines

More information

Adjunctive Antithrombotic for PCI. SCAI Fellows Course December 9, 2013

Adjunctive Antithrombotic for PCI. SCAI Fellows Course December 9, 2013 Adjunctive Antithrombotic for PCI SCAI Fellows Course December 9, 2013 Theodore A Bass, MD FSCAI President SCAI Professor of Medicine, University of Florida Medical Director UF Shands CV Center,Jacksonville

More information

Preoperative Management of Patients Receiving Antithrombotics

Preoperative Management of Patients Receiving Antithrombotics Preoperative Management of Patients Receiving Antithrombotics Bleeding complications remain an important concern for most surgical procedures. Attempts to minimize the risk of these complications by removing

More information

ANTITHROMBOTIC THERAPY 2010 Antitrombotik tedavi alan hastalarda operasyon hazırlığı

ANTITHROMBOTIC THERAPY 2010 Antitrombotik tedavi alan hastalarda operasyon hazırlığı ANTITHROMBOTIC THERAPY 2010 Antitrombotik tedavi alan hastalarda operasyon hazırlığı Dr. Sabri DEMİRCAN Ondokuz Mayıs Üniversitesi Tıp Fakültesi Kardiyoloji ABD, Samsun Copyright 2001 Harcourt Canada Ltd.

More information

Venous Thromboembolism Prophylaxis: Checked!

Venous Thromboembolism Prophylaxis: Checked! Venous Thromboembolism Prophylaxis: Checked! William Geerts, MD, FRCPC Director, Thromboembolism Program, Sunnybrook HSC Professor of Medicine, University of Toronto National Lead, VTE Prevention, Safer

More information

2010, Metzler Helfried

2010, Metzler Helfried Perioperative Strategies in Patients on Dual Antiplatelet Drug Therapy: Noncardiac Surgery H. Metzler Department of Anaesthesiology and Intensive Care Medicine Medical University of Graz, Austria What

More information

Disclosures. Theodore A. Bass MD, FSCAI. The following relationships exist related to this presentation. None

Disclosures. Theodore A. Bass MD, FSCAI. The following relationships exist related to this presentation. None SCAI Fellows Course December 10, 2013 Disclosures Theodore A. Bass MD, FSCAI The following relationships exist related to this presentation None Current Controversies on DAPT in PCI Which drug? When to

More information

The following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS.

The following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS. Page 1 The following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS. Appendix TABLE E-1 Care-Module Trigger Events That May Indicate an Adverse

More information

OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME. TARGET AUDIENCE: All Canadian health care professionals.

OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME. TARGET AUDIENCE: All Canadian health care professionals. OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To review the use of antiplatelet agents and oral

More information

Current evidence in acute pain management. Jeremy Cashman

Current evidence in acute pain management. Jeremy Cashman Current evidence in acute pain management Jeremy Cashman Optimal analgesia Best possible pain relief Lowest incidence of side effects Optimal analgesia Best possible pain relief Lowest incidence of side

More information

ENHANCED RECOVERY PROTOCOLS FOR KNEE REPLACEMENT

ENHANCED RECOVERY PROTOCOLS FOR KNEE REPLACEMENT ENHANCED RECOVERY PROTOCOLS FOR KNEE REPLACEMENT Jeff Gadsden, MD, FRCPC, FANZCA Associate Professor Duke University Department of Anesthesiology Regional Anesthesia and Acute Pain Medicine DISCLOSURES

More information

Bleeding Management Strategies. Aiming for the best Outcomes August 27, Amit Gupta, MD FACC FSCAI Interventional Cardiologist CANM

Bleeding Management Strategies. Aiming for the best Outcomes August 27, Amit Gupta, MD FACC FSCAI Interventional Cardiologist CANM Bleeding Management Strategies Aiming for the best Outcomes August 27, 2016 Amit Gupta, MD FACC FSCAI Interventional Cardiologist CANM Learning Objectives Review the use of anti-coagulants in patients

More information

There are many advantages of spinal or epidural analgesia/anesthesia

There are many advantages of spinal or epidural analgesia/anesthesia PERIODICUM BIOLOGORUM UDC 57:61 VOL. 115, No 2, 125 130, 2013 CODEN PDBIAD ISSN 0031-5362 Overview Controversies in regional anaesthesia patient on anticoagulant therapy BRANKO TRIPKOVI] Department of

More information

Outpatient Total Knee Arthroplasty: Anesthetic Implications

Outpatient Total Knee Arthroplasty: Anesthetic Implications Outpatient Total Knee Arthroplasty: Anesthetic Implications Anthony Edelman, MD, MBA Clinical Assistant Professor Director, Division of Orthopedic Anesthesia Disclosures None Objectives Examine current

More information

REGIONAL/LOCAL ANESTHESIA and OBESITY

REGIONAL/LOCAL ANESTHESIA and OBESITY REGIONAL/LOCAL ANESTHESIA and OBESITY Jay B. Brodsky, MD Stanford University School of Medicine Jbrodsky@stanford.edu Potential Advantages Regional compared to General Anesthesia Minimal intra-operative

More information

Tailoring adjunctive antithrombotic therapy to reperfusion strategy in STEMI

Tailoring adjunctive antithrombotic therapy to reperfusion strategy in STEMI Tailoring adjunctive antithrombotic therapy to reperfusion strategy in STEMI Adel El-Etriby; MD Professor of Cardiology Ain Shams University President of the Egyptian Working Group of Interventional Cardiology

More information

Dental Management Considerations for Patients on Antithrombotic Therapy

Dental Management Considerations for Patients on Antithrombotic Therapy Dental Management Considerations for Patients on Antithrombotic Therapy Warfarin and Antiplatelet Joel J. Napeñas DDS FDSRCS(Ed) Program Director General Practice Residency Program Department of Oral Medicine

More information

Guideline Quick View: Venous Thromboembolism

Guideline Quick View: Venous Thromboembolism Guideline Quick View: Venous Thromboembolism The AORN Guideline Quick View is a key component of Guideline Essentials, a suite of online implementation tools designed to help the perioperative team translate

More information

Asif Serajian DO FACC FSCAI

Asif Serajian DO FACC FSCAI Anticoagulation and Antiplatelet update: A case based approach Asif Serajian DO FACC FSCAI No disclosures relevant to this talk Objectives 1. Discuss the indication for antiplatelet therapy for cardiac

More information

Keywords: Peripheral nerve blocks for total hip arthroplasty; common anticoagulation medications; anticoagulation in regional anesthesia

Keywords: Peripheral nerve blocks for total hip arthroplasty; common anticoagulation medications; anticoagulation in regional anesthesia 64 th Annual Postgraduate Symposium on Anesthesiology Department of Anesthesiology Kansas University Medical Center Problem Based Learning Discussion Does Anti coagulation Mean Anti regional??? Contact

More information

3/23/2017. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate Europace Oct;14(10): Epub 2012 Aug 24.

3/23/2017. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate Europace Oct;14(10): Epub 2012 Aug 24. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Explain the efficacy and safety of triple therapy, in regards to thromboembolic and bleeding risk Summarize the guideline recommendations

More information

ASA PLAVIX AND PREOPERATIVE OPTIMIZATION. John Hann, MD

ASA PLAVIX AND PREOPERATIVE OPTIMIZATION. John Hann, MD ASA PLAVIX AND PREOPERATIVE OPTIMIZATION John Hann, MD QUESTIONS: WHICH ANTI-PLATELETS DO YOU STOP AND WHEN? 1. 65 yo M with history of stroke on ASA PreOp eval for cataracts surgery 2. 65 yo M with RCRI

More information

ADVOCATE HEALTHCARE GUIDELINE FOR ANTITHROMBOTIC REVERSAL

ADVOCATE HEALTHCARE GUIDELINE FOR ANTITHROMBOTIC REVERSAL Minimal clinical evidence exists to support the efficacy of nonspecific procoagulant therapies that promote thrombin formation and antifibrinolytics in the setting of antithrombotic-related bleeding. Hemostatic

More information

Dr Ben Edwards Consultant Anaesthetist Sheffield Teaching Hospitals

Dr Ben Edwards Consultant Anaesthetist Sheffield Teaching Hospitals Dr Ben Edwards Consultant Anaesthetist Sheffield Teaching Hospitals 70-75,000 #NOF per annum (costs 2 billion) 10% die within 1 month 33% die within 1 year Operative delays >48hs more than doubles risk

More information

SESSION 5 2:20 3:35 pm

SESSION 5 2:20 3:35 pm SESSION 2:2 3:3 pm Strategies to Reduce Cardiac Risk for Noncardiac Surgery SPEAKER Lee A. Fleisher, MD Presenter Disclosure Information The following relationships exist related to this presentation:

More information

Learning Objectives. Epidemiology of Acute Coronary Syndrome

Learning Objectives. Epidemiology of Acute Coronary Syndrome Cardiovascular Update: Antiplatelet therapy in acute coronary syndromes PHILLIP WEEKS, PHARM.D., BCPS-AQ CARDIOLOGY Learning Objectives Interpret guidelines as they relate to constructing an antiplatelet

More information

Adjunctive Antithrombotic for PCI. SCAI Fellows Course December 8, 2014

Adjunctive Antithrombotic for PCI. SCAI Fellows Course December 8, 2014 Adjunctive Antithrombotic for PCI SCAI Fellows Course December 8, 2014 Theodore A Bass, MD FSCAI Immediate Past-President SCAI Professor of Medicine, University of Florida Medical Director UF Health CV

More information

Nerve Blocks & Long Acting Analgesia for Plastic Surgeons. Karol A Gutowski, MD, FACS

Nerve Blocks & Long Acting Analgesia for Plastic Surgeons. Karol A Gutowski, MD, FACS Nerve Blocks & Long Acting Analgesia for Plastic Surgeons Karol A Gutowski, MD, FACS Disclosures None related to this topic Why is Non-Opioid Analgesia Important Opioid epidemic Less opioid use Less PONV

More information

Guideline for STEMI. Reperfusion at a PCI-Capable Hospital

Guideline for STEMI. Reperfusion at a PCI-Capable Hospital MANSOURA. 2015 Guideline for STEMI Reperfusion at a PCI-Capable Hospital Mahmoud Yossof MANSOURA 2015 Reperfusion Therapy for Patients with STEMI *Patients with cardiogenic shock or severe heart failure

More information

GUIDELINES FOR PERIPHERAL NERVE / PLEXUS BLOCK CATHETER MANAGEMENT DEPARTMENT OF ANAESTHESIOLOGY AND INTENSIVE CARE HOSPITAL KUALA LUMPUR

GUIDELINES FOR PERIPHERAL NERVE / PLEXUS BLOCK CATHETER MANAGEMENT DEPARTMENT OF ANAESTHESIOLOGY AND INTENSIVE CARE HOSPITAL KUALA LUMPUR GUIDELINES FOR PERIPHERAL NERVE / PLEXUS BLOCK CATHETER MANAGEMENT DEPARTMENT OF ANAESTHESIOLOGY AND INTENSIVE CARE HOSPITAL KUALA LUMPUR INTRODUCTION Regional block provides superior pain relief, compared

More information

Venous Thromboembolism Prophylaxis

Venous Thromboembolism Prophylaxis Approved by: Venous Thromboembolism Prophylaxis Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: Date Approved January

More information

Dr Brigitta Brandner UCLH

Dr Brigitta Brandner UCLH Dr Brigitta Brandner UCLH 2.5% paraplegia/paraparesis (EUROSTAR) Some studies up to 8% Immediate, recurrent and delayed 37% deficits are delayed: present 13 hours 91 days post op >50% will resolve with

More information

Xarelto (rivaroxaban) Prescriber Guide

Xarelto (rivaroxaban) Prescriber Guide Xarelto (rivaroxaban) Prescriber Guide October 2018 PP-XAR-IE-0031 Contents Patient Alert Card 4 Dosing Recommendations 4 Stroke prevention in adult patients with non-valvular atrial fibrillation 4 Patients

More information

Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017

Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Explain the efficacy and safety of triple therapy, in regards to thromboembolic and bleeding risk Summarize the guideline recommendations

More information

Guidelines PATHOLOGY: FATAL PERIOPERATIVE MI NON-PMI N = 25 PMI N = 42. Prominent Dutch Cardiovascular Researcher Fired for Scientific Misconduct

Guidelines PATHOLOGY: FATAL PERIOPERATIVE MI NON-PMI N = 25 PMI N = 42. Prominent Dutch Cardiovascular Researcher Fired for Scientific Misconduct PATHOLOGY: FATAL PERIOPERATIVE MI NON-PMI N = 25 PMI N = 42 Preoperative, Intraoperative, and Postoperative Factors Associated with Perioperative Cardiac Complications in Patients Undergoing Major Noncardiac

More information

DISCLOSURE. What I am Talking About. Rational Use of Antiplatelet Agents. Aspirin. Tom DeLoughery, MD MACP FAWM

DISCLOSURE. What I am Talking About. Rational Use of Antiplatelet Agents. Aspirin. Tom DeLoughery, MD MACP FAWM Rational Use of Antiplatelet Agents DISCLOSURE Relevant Financial Relationship(s) Speaker Bureau None Tom DeLoughery, MD MACP FAWM Oregon Health and Sciences University What I am Talking About 1. Current

More information

Perioperative Pain Management

Perioperative Pain Management Perioperative Pain Management Overview and Update As defined by the Anesthesiologist's Task Force on Acute Pain Management are from the practice guidelines from the American Society of Anesthesiologists

More information

COMPLICATIONS AND INTERVENTIONS ASSOCIATED WITH EPIDURAL ANALGESIA FOR POSTOPERATIVE PAIN RELIEF IN A TERTIARY CARE HOSPITAL

COMPLICATIONS AND INTERVENTIONS ASSOCIATED WITH EPIDURAL ANALGESIA FOR POSTOPERATIVE PAIN RELIEF IN A TERTIARY CARE HOSPITAL COMPLICATIONS AND INTERVENTIONS ASSOCIATED WITH EPIDURAL ANALGESIA FOR POSTOPERATIVE PAIN RELIEF IN A TERTIARY CARE HOSPITAL Faraz Shafiq *, Mohammad Hamid ** and Khalid Samad *** Introduction Epidural

More information

ERAS: Enhanced Recovery After Surgery. Christopher L. Wu, M.D. Professor of Anesthesiology The Johns Hopkins University; Baltimore, Maryland

ERAS: Enhanced Recovery After Surgery. Christopher L. Wu, M.D. Professor of Anesthesiology The Johns Hopkins University; Baltimore, Maryland ERAS: Enhanced Recovery After Surgery Christopher L. Wu, M.D. Professor of Anesthesiology The Johns Hopkins University; Baltimore, Maryland Overview History and basic principles of ERAS Review published

More information

This Epidural Catheter Is Not Working Well. What Should I Do? Miguel A. Cruz, M.D. Cleveland Clinic Foundation, Cleveland, OH

This Epidural Catheter Is Not Working Well. What Should I Do? Miguel A. Cruz, M.D. Cleveland Clinic Foundation, Cleveland, OH Session: L150 This Epidural Catheter Is Not Working Well. What Should I Do? Miguel A. Cruz, M.D. Cleveland Clinic Foundation, Cleveland, OH Disclosures: This presenter has no financial relationships with

More information

Milestone Guide. CBD Anesthesia

Milestone Guide. CBD Anesthesia Table of Contents Department of Anesthesiology Foundations 1 Airway 1 Pharmacology 1 Physiology 1 Common Uncomplicated Anesthetics Practice 2 Obstetrics 2 Pain 2 Core 3 Perioperative Medicine 3 Complex

More information

Complications and contraversies in the practice of neuraxial anaesthesia

Complications and contraversies in the practice of neuraxial anaesthesia Complications and contraversies in the practice of neuraxial anaesthesia SARA Spring meeting Fribourg, 2015 S. Gligorijevic Clinic Hirslanden Zürich Zürich, Switzerland Perioperative regional anaesthesia

More information

Intravenous lidocaine infusions. Dr Ian McConachie FRCA FRCPC

Intravenous lidocaine infusions. Dr Ian McConachie FRCA FRCPC Intravenous lidocaine infusions Dr Ian McConachie FRCA FRCPC Thank the organisers for inviting me. No conflicts or disclosures Lidocaine 1 st amide local anesthetic Synthesized in 1943 by Lofgren in Sweden.

More information

Orthopedic Surgery for Adults with Cerebral Palsy- Medical Considerations. Disclosures. Objectives. Adults with Cerebral Palsy

Orthopedic Surgery for Adults with Cerebral Palsy- Medical Considerations. Disclosures. Objectives. Adults with Cerebral Palsy Orthopedic Surgery for Adults with Cerebral Palsy- Medical Considerations American Academy for Cerebral Palsy and Developmental Medicine, 2013, IC 6 Garey Noritz, MD, FAAP, FACP Nationwide Children s Hospital

More information

Slide 1: Perioperative Management of Anticoagulation

Slide 1: Perioperative Management of Anticoagulation Perioperative Management of Anticoagulation by Steven L. Cohn, MD, FACP Director, Medical Consultation Service, Kings County Hospital Center, Clinical Professor of Medicine, SUNY Downstate, Brooklyn, NY

More information

Perioperative Management of anticoagulant medications

Perioperative Management of anticoagulant medications 1 Perioperative Management of anticoagulant medications Multiple Choice Questions Please select each statement as true or false 1 New Oral Anticoagulant Drugs (NOACs) a) Have longer half-lives than warfarin

More information

Multi-Modal Pain Management

Multi-Modal Pain Management Multi-Modal Pain Management July 14th, 2017 Todd Edmiston, MD Disclosures None Fellowship training in Sports and Adult Reconstruction Director of Orthopaedic Center, South Baldwin Regional Medical Center,

More information

Clinical Controversies in Perioperative Medicine

Clinical Controversies in Perioperative Medicine Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Cardiac Evaluation: New Guidelines A 70-y.o. man with progressive

More information

DECLARATION OF CONFLICT OF INTEREST. Lecture fees: AstraZeneca, Ely Lilly, Merck.

DECLARATION OF CONFLICT OF INTEREST. Lecture fees: AstraZeneca, Ely Lilly, Merck. DECLARATION OF CONFLICT OF INTEREST Lecture fees: AstraZeneca, Ely Lilly, Merck. Risk of stopping dual therapy. S D Kristensen, FESC Aarhus Denmark Acute coronary syndrome: coronary thrombus Platelets

More information

Preoperative Cardiac Evaluation:

Preoperative Cardiac Evaluation: Preoperative Cardiac Evaluation: The New Guidelines Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Disclosures No financial relationships with pharmaceutical

More information

Objectives 9/7/2012. Optimizing Analgesia to Enhance the Recovery After Surgery CME FACULTY DISCLOSURE

Objectives 9/7/2012. Optimizing Analgesia to Enhance the Recovery After Surgery CME FACULTY DISCLOSURE Optimizing Analgesia to Enhance the Recovery After Surgery Francesco Carli, M.D.. McGill University, Montreal, QC, Canada. ASPMN, Baltimore, 2012 CME FACULTY DISCLOSURE Francesco Carli has no affiliation

More information

Regional Anesthesia. Fatiş Altındaş Dept. of Anesthesiology

Regional Anesthesia. Fatiş Altındaş Dept. of Anesthesiology Regional Anesthesia Fatiş Altındaş Dept. of Anesthesiology Regional anesthesia - Definition Renders a specific area of the body, e.g. foot, arm, lower extremities insensating to stimulus of surgery or

More information

Xarelto rivaroxaban Prescriber Guide

Xarelto rivaroxaban Prescriber Guide Xarelto rivaroxaban Prescriber Guide Patient Alert Card A patient alert card must be provided to each patient who is prescribed Xarelto 2.5 mg, 10 mg, 15 mg or 20 mg and is provided with the product package.

More information

Update in Perioperative Anticoagulation and Antiplatelet management

Update in Perioperative Anticoagulation and Antiplatelet management Update in Perioperative Anticoagulation and Antiplatelet management Grand Rounds October 31, 2014 Brooke Hall, MD Steve Kornfeld, MD Bruce McLellan, MD Nothing to disclose Objectives Describe the updates

More information

Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής. Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά

Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής. Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά International ACS guidelines: Recommendations on duration of dual

More information

Objectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk?

Objectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk? Objectives Venous Thromboembolism (VTE) Prophylaxis Rishi Garg, MD Department of Medicine Identify patients at risk for VTE Options for VTE prophylaxis Current Recommendations (based on The Seventh ACCP

More information

Keeping Coronary Stents Patent in Patients Priya Kumar, M.D. University of North Carolina, Chapel Hill, NC

Keeping Coronary Stents Patent in Patients Priya Kumar, M.D. University of North Carolina, Chapel Hill, NC Session: L232 Session: L432 Keeping Coronary Stents Patent in Patients Priya Kumar, M.D. University of North Carolina, Chapel Hill, NC Disclosures: This presenter has no financial relationships with commercial

More information

Antiplatelet and Anticoagulant Therapy Management Surrounding Regional Anesthesia

Antiplatelet and Anticoagulant Therapy Management Surrounding Regional Anesthesia 1 Antiplatelet and Anticoagulant Therapy Management Surrounding Regional Anesthesia Key Points: Neuraxial complications are extremely rare. Epidural hematomas are one possible complication of neuraxial

More information

Thoracic epidural anesthesia and epidural hematoma.

Thoracic epidural anesthesia and epidural hematoma. Thoracic epidural anesthesia and epidural hematoma. Persson, J; Flisberg, Per; Lundberg, Johan Published in: Acta Anaesthesiologica Scandinavica DOI: 10.1034/j.1399-6576.2002.460921.x Published: 2002-01-01

More information

DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE)

DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) Introduction VTE (DVT/PE) is an important complication in hospitalized patients Hospitalization for acute medical illness

More information

AN AUDIT: THROMBOPROPHYLAXIS FOR TOTAL HIP REPLACEMENT PATIENTS AT NORTHWICK PARK AND CENTRAL MIDDLESEX HOSPITALS

AN AUDIT: THROMBOPROPHYLAXIS FOR TOTAL HIP REPLACEMENT PATIENTS AT NORTHWICK PARK AND CENTRAL MIDDLESEX HOSPITALS The West London Medical Journal 2010 Vol 2 No 4 pp 19-24 AN AUDIT: THROMBOPROPHYLAXIS FOR TOTAL HIP REPLACEMENT PATIENTS AT NORTHWICK PARK AND CENTRAL MIDDLESEX HOSPITALS Soneji ND Agni NR Acharya MN Anjari

More information

WARFARIN: PERI OPERATIVE MANAGEMENT

WARFARIN: PERI OPERATIVE MANAGEMENT WARFARIN: PERI OPERATIVE MANAGEMENT OBJECTIVE: To provide an approach to the perioperative management of warfarin treated patients who require an elective or urgent surgery/procedure. To provide an approach

More information

Anaesthesia and Pain Management for Endo Exo Femoral Prosthesis (EEFP) Bridging the Gap from Surgery to Rehabilitation

Anaesthesia and Pain Management for Endo Exo Femoral Prosthesis (EEFP) Bridging the Gap from Surgery to Rehabilitation Anaesthesia and Pain Management for Endo Exo Femoral Prosthesis (EEFP) Bridging the Gap from Surgery to Rehabilitation Dr Ajay Kumar Senior Lecturer Macquarie and Melbourne University Introduction Amputee

More information

Acute Coronary Syndromes

Acute Coronary Syndromes Overview Acute Coronary Syndromes Rabeea Aboufakher, MD, FACC, FSCAI Section Chief of Cardiology Altru Health System Grand Forks, ND Epidemiology Pathophysiology Clinical features and diagnosis STEMI management

More information

Coagulation management in epidural steroid injection

Coagulation management in epidural steroid injection PRACE POGLĄDOWE Anestezjologia Intensywna Terapia 2014, tom 46, numer 3, 209 213 ISSN 0209 1712 www.ait.viamedica.pl Coagulation management in epidural steroid injection Martina Bellini, Massimo Barbieri

More information

Prostate Biopsy Alerts

Prostate Biopsy Alerts Prostate Biopsy Alerts Saskatchewan Prostate Assessment Pathway Guidelines for the Primary Care Provider for Patient Preparation and the Management of Medications and Complications September 2016 Table

More information

Update Update on Anaesthesia for c-section Dr Kerry Litchfield Consultant Anaesthetist Princess Royal Maternity Glasgow, Scotland

Update Update on Anaesthesia for c-section Dr Kerry Litchfield Consultant Anaesthetist Princess Royal Maternity Glasgow, Scotland Update Update on Anaesthesia for c-section Dr Kerry Litchfield Consultant Anaesthetist Princess Royal Maternity Glasgow, Scotland Caesarean section is the most common surgical procedure in the world 1

More information

Sign up to receive ATOTW weekly -

Sign up to receive ATOTW weekly - ANAESTHESIA FOR TOTAL KNEE REPLACEMENT ANAESTHESIA TUTORIAL OF THE WEEK 76 3RD DECEMBER 2007 Dr Helen Bromhead, Locum Consultant Anaesthetist Royal Hampshire County Hospital UK e mail: hjbromhead@hotmail.com

More information

2017 Bryan Health Primary Care Conference. Dale Hansen MD Bryan Heart 5/20/17

2017 Bryan Health Primary Care Conference. Dale Hansen MD Bryan Heart 5/20/17 2017 Bryan Health Primary Care Conference Dale Hansen MD Bryan Heart 5/20/17 I have no financial disclosures or conflicts of interest Bridging Anticoagulation Primum Non Nocere 67 y.o. male with mechanical

More information

Red de Revistas Científicas de América Latina y el Caribe, España y Portugal. Universidad Autónoma del Estado de México

Red de Revistas Científicas de América Latina y el Caribe, España y Portugal. Universidad Autónoma del Estado de México Revista Mexicana de Anestesiología Colegio Mexicano de Anestesiología mariram@prodigy.net.mx, revistacma@mail.medinet.net.mx ISSN (Versión impresa): 0185-1012 MÉXICO 2006 Terese T. Horlocker ANALGESIA

More information

Factor Xa Inhibition in the Management of Venous Thromboembolism: Important Safety Information. Important Safety Information (cont d)

Factor Xa Inhibition in the Management of Venous Thromboembolism: Important Safety Information. Important Safety Information (cont d) Factor Xa Inhibition in the Management of Venous Thromboembolism: The Role of Fondaparinux WARNING: SPINAL/EPIDURAL HEMATOMAS Epidural or spinal hematomas may occur in patients who are anticoagulated with

More information

Which Patients are Too High Risk for Ambulatory Surgery?

Which Patients are Too High Risk for Ambulatory Surgery? Which Patients are Too High Risk for Ambulatory Surgery? BobbieJean Sweitzer, M.D. Director, Anesthesia Perioperative Medicine Clinic Professor of Anesthesia and Critical Care Professor of Medicine University

More information

Update on Antithrombotic Therapy in Acute Coronary Syndrome

Update on Antithrombotic Therapy in Acute Coronary Syndrome Update on Antithrombotic Therapy in Acute Coronary Syndrome Laura Tsang November 13, 2006 Objectives: By the end of this session, you should understand: The role of antithrombotics in ACS Their mechanisms

More information

Complications of Regional Anesthesia and Acute Pain Management

Complications of Regional Anesthesia and Acute Pain Management Complications of Regional Anesthesia and Acute Pain Management Terese T. Horlocker, MD KEYWORDS Perioperative nerve injuries Regional anesthesia Neurologic deficits Surgical complications Perioperative

More information

Aspirin as Venous Thromboprophylaxis

Aspirin as Venous Thromboprophylaxis Canadian Society of Internal Medicine Nov 2, 2017 Aspirin as Venous Thromboprophylaxis Bill Geerts, MD, FRCPC Thromboembolism Consultant, Sunnybrook HSC Professor of Medicine, University of Toronto Disclosures

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Adverse drug events, polypharmacy and perioperative considerations in elderly patients, 377 389 Age, and risk of postoperative urinary retention,

More information

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None Pre-op Evaluation for non cardiac surgery John Steuter, MD Disclosures None A quick review from 2007!! Fliesheret al, ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and are for Noncardiac

More information

Balancing Efficacy and Safety of P2Y12 Inhibitors for ACS Patients

Balancing Efficacy and Safety of P2Y12 Inhibitors for ACS Patients SYP.CLO-A.16.07.01 Balancing Efficacy and Safety of P2Y12 Inhibitors for ACS Patients dr. Hariadi Hariawan, Sp.PD, Sp.JP (K) TOPICS Efficacy Safety Consideration from Currently Available Antiplatelet Agents

More information